On August 13, 2026, BELITE BIO, INC reached its earnings. The result was a negative outcome, and the stock moved -7.1% in the window around the event. It had already run +14.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$178.94
1d before
$166.28
Event day
$162.80
1d after
$162.57
5d after
Our prediction vs. the result
CatalystAlert called this one neutral (+0.6% expected); the stock actually moved -7.1%. Model confidence at the time: 40%.
See the full scored track recordPre-catalyst setup
+14.0%
30-day run-up
3919%
30-day volatility
1.0×
volume spike